Results 211 to 220 of about 34,423 (243)

Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter

Biochimica Et Biophysica Acta: Reviews on Cancer, 2021
Guopei Luo, Chen Liu, Xianjun Yu
exaly  

CA19-9 beim intrahepatischen Cholangiokarzinom

Der Chirurg, 2018
Juntermanns, Benjamin, Kaiser, Gernot Maximil, Itani Gutierrez, S., Heuer, Matthias, Büchter, Matthias, Kahraman, Alisan, Reis, Henning, Kasper, Stefan, Paul, Andreas, Fingas, Christian   +9 more
openaire   +2 more sources

CA19-9 Antigen

2020
openaire   +1 more source

The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice

Science, 2019
Dannielle D Engle, Herve Tiriac, Keith D Rivera   +2 more
exaly  

CA19-9 Level Finding

2020
openaire   +1 more source

Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis

Biomarkers, 2020
Labrinus van Manen, Jesse Groen, Hein Putter   +2 more
exaly  

Perioperative CA19-9 Levels Can Predict Stage and Survival in Patients With Resectable Pancreatic Adenocarcinoma

Journal of Clinical Oncology, 2006
Dianne M Finkelstein, Carlos Fernandez-Del Castillo, Andrew L Warshaw   +2 more
exaly  

CA19-9

2008
openaire   +1 more source

Serum CA19-9 Abnormal

2020
openaire   +1 more source

CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer

Annals of Oncology, 2016
Josep Tabernero Caturla
exaly